Medicus Pharma Ltd. (CVE:MDC – Free Report) – Equities researchers at Brookline Capital Management raised their FY2025 earnings per share (EPS) estimates for shares of Medicus Pharma in a research report issued on Tuesday, April 8th. Brookline Capital Management analyst K. Raja now expects that the company will post earnings of ($1.25) per share for the year, up from their prior forecast of ($2.20). Brookline Capital Management also issued estimates for Medicus Pharma’s FY2026 earnings at ($1.22) EPS, FY2027 earnings at ($0.92) EPS and FY2028 earnings at $0.62 EPS.
Medicus Pharma Stock Performance
Further Reading
- Five stocks we like better than Medicus Pharma
- How to Profit From Value Investing
- JPMorgan is a Buy, if You Can Handle The Volatility
- Unveiling The Power Of VWAP: A Key Indicator For Traders
- United States Steel’s Crash: An Unmissable Buying Opportunity
- What is a Low P/E Ratio and What Does it Tell Investors?
- Rocket Lab Stock: Weathering the Storm, Time for a Comeback?
Receive News & Ratings for Medicus Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medicus Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
